Skip to search.
 FTSE 100 Down 0.11%
Streaming
Ticker Tape: On

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
6.16 Down 0.18(2.84%) 23 Apr 21:00
Add to Portfolio
Prev Close:6.34
Open:6.31
Bid:6.15 x 900
Ask:6.24 x 5000
1y Target Est:7.83
Beta:-2.3
Earnings Date:28 Apr - 2 May (Est.)
Day's Range:6.11 - 6.33
52wk Range:4.05 - 9.25
Volume:4,828,196
Avg Vol (3m):5,544,230
Market Cap:1.35b
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 2.84%1.35b
GSKDown 0.29%132.09b
OREXDown 2.81%617.92m
RHHBYDown 0.14%123.01b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.41
Quarterly EPS Est (Mar-14) :-0.10
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback